Imegen Overview

  • Founded
  • 2009
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 65
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 3

Imegen General Information

Description

Provider of genetics and genomics diagnosis services created to collaborate intensively in medical training and popular science. The company's genetics diagnosis services offers and extend a dynamic test catalog to detect any genetic disease with known scientific evidences based on the application of Deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) analysis technologies, enabling individuals, families, hospitals and other healthcare institutions to improve people's quality of life by putting genetics at their service.

Contact Information

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Parent Company
Primary Office
  • C Agustín Escardino 9
  • Parc Científic de la Universitat de València
  • 46980 Paterna
  • Spain
+34 963 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Imegen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Imegen‘s full profile, request access.

Request a free trial

Imegen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of genetics and genomics diagnosis services created to collaborate intensively in medical training and popular
Biotechnology
Paterna, Spain
65 As of 2019
00000
000000000000

00000

rit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidata
0000000000000
Tübingen, Germany
0 As of 0000
000000000000

00000000

iusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exe
00000 0000000000 00000000
Rostock, Germany
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Imegen Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CeGaT Corporate Backed or Acquired Tübingen, Germany 0 000000000000
000000000 Formerly VC-backed Rostock, Germany 000 00000 00000000 00000
00000000000 000000 Corporate Backed or Acquired Ingelheim, Germany 0000 000000&0
To view Imegen’s complete competitors history, request access »

Imegen Executive Team (5)

Name Title Board Seat Contact Info
Ángela Pérez Co-Founder, Chief Executive Officer & Co-Directora General
Isaías Rodríguez Chief Financial Officer
Carlos Ruiz Lafora Ph.D Chief Technology Officer & Chief Operating Officer
Manuel Perez-Alonso Ph.D Scientific Advisor
To view Imegen’s complete executive team members history, request access »

Imegen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Imegen Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Imegen‘s full profile, request access.

Request a free trial